CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
Atorvastatin 20mg +1 moredrug
Likely dose
Atorvastatin 20mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03966859
NCT03966859N/ACompleted

The Effect of Seven-Day Atorvastatin Administration on Emotional Processing, Reward Processing, and Inflammation in Healthy Volunteers

University of Oxford·interventional·Posted May 29, 2019·Updated Dec 1, 2020

In Brief

A clinical study evaluating Atorvastatin 20mg and Lactose placebo for Healthy. Completed, enrolled 50 participants across 1 site.

Detailed Summary

Work in our group has revealed that short-term (7-day) administration of antidepressants produces positive biases in the processing of emotional information in healthy volunteers. Such effect might be an important neuropsychological mechanism of antidepressant action. The current study will investigate the effect of seven-day administration of atorvastatin 20mg on emotional and reward processing tasks in healthy volunteers. There is evidence that statins may exert antidepressant effects via anti-inflammatory and anti-oxidant pathways, and it is therefore predicted that atorvastatin will have positive effects on emotional and reward processing.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited Kingdom
CollaboratorsWellcome Trust

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedMay 29, 2019
Enrollment StartJun 19, 2019
Primary CompletionFeb 1, 2020
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 7.1 years ago

Interventions

Atorvastatin 20mgdrug

oral dose, once daily for 7 days

Lactose placeboother

oral dose, once daily for 7 days